Gastrointestinal tuberculosis is defined as infection of the peritoneum, hollow or solid abdominal organs, and abdominal lymphatics with Mycobacterium tuberculosis organisms. Gastrointestinal tuberculosis is relatively rare in the United States and is the sixth most common extrapulmonary location. Populations at risk include immigrants to the United States, the homeless, prisoners, residents of long-term care facilities, and the immunocompromised. The peritoneum and the ileocecal region are the most likely sites of infection and are involved in the majority of cases by hematogenous spread or through swallowing of infected sputum from primary pulmonary tuberculosis. Pulmonary tuberculosis is apparent in less than half of patients. Patients usually present with abdominal pain, weight loss, fever, anorexia, change in bowel habits, nausea, and vomiting. The diagnosis is often delayed and is usually made through a combination of radiologic, endoscopic, microbiologic, histologic, and molecular techniques. Antimicrobial treatment is the same as for pulmonary tuberculosis. Surgery is occasionally required.
KeywordsTuberculosis Infliximab Pulmonary Tuberculosis Directly Observe Therapy Abdominal Tuberculosis
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 1.CDC Surveillance Reports: Reported tuberculosis in the United States, 2001. http:/www.cdc.gov/nchstp/tb/surv/ surv2001/default.htm. Accessed December 1, 2002.Google Scholar
- 21.Mitchel RS: The prognosis of bilateral symmetrical diffuse nodular pulmonary tuberculosis and its possible relation to intestinal tuberculosis. Dis Chest 1956, 29:669–674.Google Scholar
- 22.Al Muneef M, Memish Z, Al Mahmoud S, et al.: Tuberculosis in the belly: a review of forty-six cases involving the gastrointestinal tract and peritoneum. Scand J Gastroenterol 2001, 36:528–532. Well-organized collection of 46 cases of abdominal tuberculosis accrued over 11 years that provides a good synopsis of the presentations and laboratory, radiologic, and microbiologic findings.Google Scholar
- 33.Keane J, Gershon S, Wise RP, et al.: Tuberculosis associated with infliximab, a tumor necrosis factor _-neutralizing agent. N Engl J Med 2001, 345:1098–1104. Analysis of all cases of tuberculosis after treatment with infliximab reported to the US Food and Drug Administration as of May 2001. Recommends that all patients with latent tuberculosis be given prophylactic treatment prior to administration of infliximab.PubMedCrossRefGoogle Scholar
- 39.Aoki G, Nagasaki K, Nakae Y: The fibercolonoscopic diagnosis of intestinal tuberculosis. Endoscopy 1971, 7:113–118.Google Scholar
- 48.Gan H, Ouyang Q, Bu H: The value of polymerase chain reaction assay in the diagnosis of intestinal tuberculosis and differentiation from Crohn’s disease. Chin J Intern Med 1995, 34:30–33.Google Scholar
- 50.American Thoracic Society: Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994, 149:1359–1374.Google Scholar